A B S T R A C T The effects on some host defenses of murine cytomegalovirus (MCMV) and(or) EL4, a mouse ascites homograft, were studied in mice. Assays of cellular and humoral immunity in response to either or both of these perturbations were carried out by quantitation of various immune activities.
INTRODUCTION
The hosts of infectious agents, homografts, and certain tumors share a partial dependence on cell-mediated immunity and humoral immunity for survival (1) (2) (3) (4) (5) (6) (7) (8) . It is not certain that all the same recognition and effector processes are involved but it seems likely that there are common mechanisms and interactions, both enhancing and suppressing the cellular response to these foreign agents.
Clinical evidence exists to support the hypothesis that there are interactions between infections and grafts. For example, the increased risk and variety of infections seen in patients with renal homografts is well known (9, 10) . Although this is undoubtedly related to the underlying disease, to increased exposure to potential pathogens, to invasive procedures, and especially to drug-induced immunosuppression, it is possible that immune mechanisms involved in graft acceptance or rejection alter the host's response to infection. Examples are the activation of latent virus (11, 12) and enhancement of infection (13, 14) .
Animal studies suggest an effect of bacteria, bacterial products, mycobacteria, viruses, and oncogenic viruses on graft survival (15) (16) (17) (18) (19) (20) (21) (22) . These studies show increased, decreased, or no effect on graft survival depending on the system. For example, Bacillus Calmette-Gu6rin reduced graft and tumor survival in both animals and humans (23) (24) (25) (26) (27) (28) (29) (30) . Simmons et al. (31) (32) (33) and Lopez et al. (34) (35) (36) suggest that renal homografts fare less well in cytomegalovirus-infected patients than in uninfected patients. Briggs et al. (37) and David et al. (38) present additional cases suggesting that viruses can enhance immunity and accelerate graft rejection. Most data, however, suggest viruses, including cytomegalovirus, as the cause of immunodepression (1, (39) (40) (41) (42) (43) . Osborne and co-workers (44-46), Selgrade et al. (47) , and Howard et al. (48, 49) specifically identified suppression of humoral and cell-mediated immunity in animals infected with murine cytomegalovirus (MCMV).' Some tumor viruses (50) and the enterotoxin 'Abbreviations used in this paper: B, bone marrow-derived; LPS, lypopolysaccharide; MCMV, murine cytomegalovirus; PBS, phosphate-buffered saline; PHA, phytohemagglutinin; T, thymus-derived.
isolated from Vibrio cholera (51, 52) are known to suppress cell-mediated immunity. This study examines some of the interrelationships between MCMV infection and host immunity to EL4, a peritoneal ascites tumor allograft. In particular, the Pffect on cell function is studied.
METHODS

Animals
Inbred strains (male and female) of specific pathogen free mice (The Jackson Laboratory, Bar Harbor, Maine) with defined histocompatibility loci were used in all experiments. [18] [19] [20] Harris (53) . The complement-fixation antigen was prepared by infecting monolayer cultures of secondary mouse embryonic fibroblasts in a roller bottle with MCMV. The infected cells were harvested 48-72 h later when the cell layer showed a 100% cytopathic effect. The infected cell layer was rinsed once with glycine buffer, pH 8.6. 30 ml of fresh buffer was added and the cells were removed from the glass surface by gentle scraping with a rubber policeman. The cell suspension was sonicated and stored in small aliquots at -700C until used.
LIGHT AND ELECTRON MICROSCOPY Spleens were excised after mouse exsanguination and photographed. For electron microscopy, blocks of splenic tissue were fixed in cacodylate-buffered glutaraldehyde. Multiple thin sections from four Epon blocks (Shell Chemical Co., Houston, Tex.) from two different animals in each experimental group were carefully examined. Areas Lymphocyte-mediated cytolysis. This was performed according to the techniques of Berke et al. (56, 57 Serum-mediated cytolysis. Sera collected from mice sacrificed in the above protocols were tested for lytic activity against 51Cr-labeled tumor cells as described by Canty et al. (58) . 50-j,l vol of serially diluted and heat inactivated serum from experimental animals were incubated at room temperature in 13 x 75-mm glass tubes for 30 min with 50 pi PBS that contained 1 x 105 51Cr-labeled target cells. The reaction was stopped with cold PBS. All tubes were centrifuged at 1,000 rpm for 10 min and the supemate discarded. The sediment was further incubated at 37°C for 45 splenocytes for 3 h in the presence of 5 x 104 5'Cr-labeled EL4 target cells. At the end of the incubation, the 5'Cr was measured in the supernate and cytolysis was calculated as previously noted.
Serum suppressor factors. Assays for inhibitory factors were perfonned by adding 100 or 10 ul (from animals infected 0, 14, and 28 days previously) to sensitized splenic lymphocytes for 1 h at room temperature before performance of the standard cytolysis (lymphocyte-mediated) procedure. Control animal sera and sera from animals only grafted were also tested.
STATISTICS
The P value was calculated with the "t" statistic of means. Further statistical control for multiple comparisons within a mitogen stimulation category was accomplished by adjusting the effective significance level of tests with Bonferroni's inequality correction (59) .
RESULTS
Viral isolation, distribution, and infection
No deaths or recognized disease caused by MCMV were observed in any of the animals tested. Peak salivary gland virus titers averaged 2.5 x 106 plaqueforming units per gram of tissue at 11 days after infection, falling to undetectable levels by 28 days after infection in ungrafted mice. Splenic viral titers were less than those in salivary gland by 25 days after infection. In animals both infected and grafted, salivary viral titers were comparable to those only infected (Fig. 1) . In one instance, virus in low titer was detected in the spleen at 8 days in an animal both infected and grafted. Mean anti-MCMV complement-fixing antibody titers were not different for animals infected and grafted or only infected (Fig. 1 ).
Morphology and microscopy
The spleens from infected animals were smaller than those from control and grafted animals. Total cell counts confirmed significant (P < 0.01) differences (Fig.  2) . Light microscopic examination of the spleens from animals infected 18 days before showed massive necrosis and no viral inclusions, whereas the grafted only spleens showed increased cellularity and no identifiable tumor. Spleens from animals both infected and grafted had some necrosis and disorganization of normal architecture but less than in 11 days. PHA and LPS responsiveness in this latter group remained reduced but less so than when the animals were only infected. In the animals infected 18 days previously, uptake was still increased in the LPS stimulated group but less so than when the animals were only grafted.
Mixed lymphocyte cultures 
Cytolysis
In the model system used, cell-and serum-mediated cytolysis and peritoneal cell counts developed normally as outlined in Fig. 3 . Measurable serummediated cvtolysis developed on day 5 after EL4 injection and rose rapidly to a plateau by day 7, where it remained through day 14. Cell-mediated cytolysis was measurable in the spleen by day 7 and progressively increased to day 14. Peritoneal cell counts, which were mostly proliferating EL4 tumor cells, peaked between days 4 and 7 and then, cell counts decreased to base-line levels. Day 11 was selected as an appropriate interval for most subsequent studies in which the system was perturbed by superimposed cytomegalovirus infections at various intervals.
Lymphocyte-mediated cytolysis. Neither normal controls nor infected only animals had any demonstrable lymphocyte-mediated cytolysis against EL4 target cells at any intervals after infection. A dose-response study showed increasingly suppressive effects with doses of MCMV from 102 to 105 plaque-forming units. A dose of 104 particles was selected for later experiments. Serum-mediated cytolysis. Fig. 5 illustrates the results of serum-mediated cytolysis in the same animals. Controls were appropriately negative or positive in ungrafted and sensitized or hypersensitized animals, respectively. Animals only infected but not grafted had no detectable anti-EL4 activity at the intervals 0, -14, and -28 days. In comparison to grafted animals, however, infected and grafted animals had significantly lower titers at the -7, -14, -21, and -28 days intervals. As with lymphocyte-mediated cytolysis, maximal depression occurred at -7 days with less depression by day -28.
Peritoneal cell numbers, all in nonbloody fluids, were measured by the absorbancy of an aliquot of aspirated peritoneal fluid. Animals both infected and grafted had more persistent cells but at no interval was the difference statistically significant from grafted only animals. The difference in types of persistent cells was previously noted. Animals that had not been grafted but were infected 0, 14, and 28 days previously had few peritoneal cells (mostly lymphocytes on smear) and the same was true of animals that had been neither infected nor grafted.
Modifier cells. The results ofthe assay for suppressor cells are noted in Table III Days After Graft Focusing more on the interrelationships of the host response to infections and homografts together, rather than individually, the EL4-MCMV mouse model provides some useful data. The mouse presumably uses a number of defense mechanisms in vivo to resist the development of progressive tumor. The measurement of the peritoneal cell counts in infected and grafted animals represents only the end result of these defense mechanisms and it is perhaps not surprising that no significant difference can be detected compared to grafted controls. If deficiencies in some mechanisms of response are induced by infection, some evidence for which has been presented, it is not unreasonable that other compensatory mechanisms exist. This paper has attempted to quantify some of these mechanisms as regards T-cell function (cytotoxicity) and B-cell function (antibody), suppressor cells, and suppressor factors.
Lymphocyte-mediated cytotoxicity and EL4 antibody plus complement studies demonstrated conclusively a time-dependent depression of the cellular and humoral response to the allograft. The time sequence, as with the mitogen response, correlated with the time of maximal organ virus proliferation and splenic damage. Treatment with anti-theta serum revealed that the cytotoxicity generated in both grafted infected and grafted only animals was a T-cell-dependent process. Berke et al. (56) reported that the cytotoxicity against EL4 was almost exclusively a T-cell function with only a small contribution from the macrophage. It is noteworthy that the viral effects on cytotoxicity (T cell) and anti EL4 antibody (B cell) are self limited with a return to graft control levels by 4-5 wk after infection.
Other explanations for the observed immunosuppressive effects of MCMV on the host response to alloantigens were sought, including suppressor cells and suppressor factors, but not found. Still other possibilities exist including alteration of macrophage function, alteration of adrenal cortical function through stress, competitive inhibition of antiallogen activity by concomitant anti-viral activity, or the contribution of virally induced altered H-2 antigenic determinants.
The hypothesis that allograft may alter the host's capacity to deal with a concomitant viral infection was examined in a limited fashion. Organ viral titers, duration of viral persistence, and anti-MCMV complementfixing antibody titers were found to be similar in animals either infected or infected and grafted. Certainly no excess mortality caused by virus was observed in those infected animals which were also grafted. Although this contrasts with the work of Wu et al. (13) a difference in original viral dose and age of animals infected could reconcile the two views.
In view of the clinical observation that viral infections and homograft rejection commonly occur simultaneously, this animal model study offers some additional but conflicting data. No evidence was found to suggest that an enhanced immunologic response to a homograft was induced by a prior infection with MCMV. Rather, a depressed response was found which was felt to be mediated by a severe reduction in the number and functional capacity of immune competent cells. The consequences of viral infection that occur after the homograft have not been determined and may yet help to explain the clinical observation.
It is nonetheless clear that both MCMV and EL4 exert measurable influences on host defenses. Some of the interrelationships have been described here.
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